Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Immucell Corp.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 4.51M 4.39M 5.11M 5.39M 6.01M
Cost of Goods Sold (COGS) incl. D&A 2.11M 2.08M 2.3M 2.34M 2.95M
COGS excluding D&A 1.68M 1.66M 1.88M 1.93M 2.53M
Depreciation & Amortization Expense 424,440 419,511 418,372 402,516 417,201
Depreciation 394,295 416,918 413,132 399,640 414,307
Amortization of Intangibles 30,145 2,593 5,240 2,876 2,894
Gross Income 2.4M 2.3M 2.81M 3.05M 3.06M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 2.93M 2.99M 3.45M 2.81M 3.08M
Research & Development 1.64M 1.49M 1.72M 917,600 1.15M
Other SG&A 1.28M 1.5M 1.73M 1.89M 1.93M
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 0 0 0 -
EBIT after Unusual Expense 0 0 0 0 -
Non Operating Income/Expense 2,234 2,869 7,045 8,099 281,902
Non-Operating Interest Income 96,292 26,000 15,000 17,202 12,493
Equity in Affiliates (Pretax) 0 0 0 - 0
Interest Expense 0 22,000 86,000 78,150 69,583
Gross Interest Expense 0 22,000 86,000 78,150 69,583
Interest Capitalized 0 0 0 0 0
Pretax Income (428,501) (683,412) (696,681) 192,152 205,260
Income Tax (212,008) (298,728) (287,171) 102,640 87,865
Income Tax - Current Domestic 992 1,000 829 0 301
Income Tax - Current Foreign 0 0 0 708 -
Income Tax - Deferred Domestic (213,000) (299,728) (288,000) 101,932 87,564
Income Tax - Deferred Foreign 0 0 0 0 -
Income Tax Credits 0 0 0 0 -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (216,493) (384,684) (409,510) 89,512 117,395
Minority Interest Expense 0 0 0 0 0
Net Income (216,493) (384,684) (409,510) 89,512 117,395
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 - - 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (216,493) (384,684) (409,510) 89,512 117,395
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (216,493) (384,684) (409,510) 89,512 117,395
EPS (Basic) (0.07) (0.13) (0.14) 0.03 0.04
Basic Shares Outstanding 2.96M 2.97M 2.98M 3.02M 3.02M
EPS (Diluted) (0.07) (0.13) (0.14) 0.03 0.04
Diluted Shares Outstanding 2.96M 2.97M 2.98M 3.11M 3.09M
EBITDA (102,587) (270,770) (214,354) 647,517 397,649
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.